GENERAL CONTRACTOR: KARMAR
INVESTOR: BIOMED Lublin Wytwórnia Surowic i Szczepionek
DESIGN OFFICE: TSE Polska
TOTAL AREA: 2 764 m2
PROJECT COMPLETION: 2023
Research & Development Center will house
a modern production line for immunopressants and oncology drugs.
Project is apart of the Center for Biotechnological Innovation – Onko BCG Department, where technologies related to vaccinology in the prevention of tuberculosis (BCG) and immunology in the treatment of cancer will be improved.
